Skip to main content

Peer Review reports

From: Oseltamivir phosphate for suspension is bioequivalent to TAMIFLU in healthy volunteers: a randomized, open-label clinical study

Original Submission
13 Aug 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
12 Oct 2022 Reviewed Reviewer Report
17 Oct 2022 Reviewed Reviewer Report - Hiroyuki Fukase
29 Oct 2022 Author responded Author comments - Huan Zhou
Resubmission - Version 4
29 Oct 2022 Submitted Manuscript version 4
2 Nov 2022 Author responded Author comments - Huan Zhou
Resubmission - Version 5
2 Nov 2022 Submitted Manuscript version 5
8 Nov 2022 Reviewed Reviewer Report
15 Nov 2022 Reviewed Reviewer Report - Hiroyuki Fukase
28 Nov 2022 Author responded Author comments - Huan Zhou
Resubmission - Version 6
28 Nov 2022 Submitted Manuscript version 6
1 Dec 2022 Author responded Author comments - Huan Zhou
Resubmission - Version 7
1 Dec 2022 Submitted Manuscript version 7
7 Dec 2022 Reviewed Reviewer Report
13 Dec 2022 Reviewed Reviewer Report - Hiroyuki Fukase
26 Dec 2022 Author responded Author comments - Huan Zhou
Resubmission - Version 8
26 Dec 2022 Submitted Manuscript version 8
8 Jan 2023 Reviewed Reviewer Report - Hiroyuki Fukase
8 Jan 2023 Reviewed Reviewer Report
19 Jan 2023 Author responded Author comments - Huan Zhou
Resubmission - Version 9
19 Jan 2023 Submitted Manuscript version 9
Publishing
23 Jan 2023 Editorially accepted
21 Feb 2023 Article published 10.1186/s40360-023-00646-1

You can find further information about peer review here.

Back to article page